ABSTRACT
A lo largo de los últimos años la implantación de Dispositivos de Asistencia Ventricular (DAV) está tomando un papel más relevante en el tratamiento de la Insuficiencia Cardíaca (IC). El uso de los DAV también está cambiando hacia la Terapia Definitiva (TD), conformándose como alternativa clara al trasplante cardíaco. La implantación de un DAV, en ocasiones, requiere previamente tratamiento emergente con otros dispositivos de Asistencia Circulatoria Mecánica (ACM) como Circulación Extracorpórea con Membrana de Oxigenación (ECMO) o Asistencia Ventricular paracorpórea Izquierda o Derecha. Por tanto, es necesario el ingreso en Unidades de Cuidados Intensivos (UCI) especializadas en estas terapias hasta la estabilización del paciente y toma de la decisión correcta. Se expone un caso clínico reciente de una persona que requiere asistencia inicial con ECMO V-A emergente en el hospital de origen y su traslado al centro de referencia para posterior asistencia biventricular paracorpórea e implantación definitiva de un DAVI (Dispositivo de Asistencia Ventricular Izquierda). Se exponen la secuencia de decisiones, complicaciones y el plan de cuidados de enfermería inicial en UCI con taxonomía NANDA. Es el primer implante de un DAVI, realizado en nuestro hospital. En él ha intervenido un enorme equipo multidisciplinar.
Over the past few years, the Ventricular Assist Devices (VADs) implementation is taking a relevant role in the Heart Failure (HF) treatment. VADs Ìs use is also shifting towards Definitive Therapy (TD), being a clear alternative to heart transplantation. The implantation of a VAD, sometimes, requires a previous emergent treatment with other Mechanical Circulatory Assistance (ACM) devices such as Extracorporeal Circulation with Oxygenation Membrane (ECMO) or Left or Right Paracorporeal Ventricular Assistance. So is necessary of a mobile team for emergency assistance with ECMO and transfer to Intensive Care Units (ICU) which is specialized in these therapies until the patient stabilizes and doctors takes the right decision. A recent clinical case of a patient is exposed. This person required assistance with emergent ECMO V-A (Venous-Arterial) in the hospital of origin and his transfer to the reference center for subsequent biventricular paracorporeal assistance and to the definitive implantation of LVAD (Left Ventricular Assist Device). The sequence of decisions, complications and the initial nursing care plan at ICU with NANDA taxonomy, are presented here. This is the first implant of a LVAD in our hospital. A huge multidisciplinary team has been involved in the project.
Subject(s)
Humans , Male , Adult , Assisted Circulation/methods , Heart-Assist Devices , Heart Failure/drug therapy , Intensive Care Units , Nursing Care , Patient Care Planning , Heart Transplantation/methods , Critical CareABSTRACT
Left ventricular assist device (LVAD) is a good treatment option for the patients ineligible for cardiac transplantation. Several studies have demonstrated that a ventricular assist device improves the quality of life and prognosis of the patients with end-stage heart failure. A 75-yr-old man debilitated with New York Heart Association (NYHA) functional class III-IV due to severe left ventricular systolic dysfunction received LVAD implantation as a destination therapy. The patient was discharged with improved functional status (NYHA functional class II) after appropriate cardiac rehabilitation and education about how to manage the device and potential emergency situations. This is the first case of successful continuous-flow LVAD implantation as a destination therapy in Korea.
Subject(s)
Aged , Humans , Male , Dyspnea , Echocardiography , Heart Failure/surgery , Heart-Assist Devices , Prosthesis Implantation , Quality of Life , Republic of Korea , Treatment Outcome , Ventricular Dysfunction, Left/surgeryABSTRACT
BACKGROUND: Fulminant myocarditis is a rare, but life threatening condition. Its prognosis is related with proper management in the acute phase. A cardiopulmonary support device can be very useful in this phase. We report on our experiences with managing acute fulminant myocarditis with a cardiopulmonary support (CPS) device. MATERIAL AND METHOD: We reviewed retrospectively 9 patients who had a CPS device used for their fulminant myocarditis between September, 2006 and October, 2008. A Capiox emergency bypass system (Terumo Inc, Tokyo, Japan) was percutaneously inserted in all the patients. Upon implantation, all the patients were in cardiogenic shock because of ventricular arrhythmia or severe left ventricular dysfunction. The mean left ventricular ejection fraction (EF) was 20+/-6% according to transthoracic echocardiography. RESULT: 3 patients died despite CPS. The CPS was bridged to a transplanted heart in one patient. The rest were successfully explanted after a mean time of 107+/-70 hours of running. The mean EF after discharge was 56+/-7% without dilated cardiomyopathy. CONCLUSION: Fulminant myocarditis can be fatal, but its prognosis is excellent if these patients receive proper, timely treatment. A cardiopulmonary support device can be very useful in this acute period. However, the implantation and management protocol of cardiopulmonary support are not yet settled. Further study is necessary to lower the complications of cardiopulmonary support for patients with fulminant myocarditis.
Subject(s)
Humans , Arrhythmias, Cardiac , Cardiomyopathy, Dilated , Echocardiography , Emergencies , Heart , Heart Transplantation , Myocarditis , Prognosis , Retrospective Studies , Running , Shock, Cardiogenic , Stroke Volume , Tokyo , Transplants , Ventricular Dysfunction, LeftABSTRACT
A 5-day-old neonate (body weight=2.4 kg) with coarctation of the aorta and critical aortic stenosis underwent an interventional balloon valvuloplasty for aortic stenosis. During the intervention, cardiac arrest occurred due to injury of the right carotid artery by the guide wire. An extracorporeal membrane oxygenator (ECMO) was applied. After 1 day's support, total surgical correction was achieved; however, in the immediate postoperative period, cardiac function was severely depressed. We applied a bi-ventricular assist device (bi-VAD) instead of an ECMO and we were able to wean the patient off the bi-VAD device after 3 days' support. The patient was discharged without severe complications.
Subject(s)
Humans , Infant, Newborn , Aortic Coarctation , Aortic Valve Stenosis , Balloon Valvuloplasty , Carotid Arteries , Extracorporeal Circulation , Extracorporeal Membrane Oxygenation , Heart Arrest , Heart-Assist Devices , Oxygenators, Membrane , Postoperative PeriodABSTRACT
Objective To investigate the relation between the changes d myocardial collagen content before and after ventricu-lar assist device (LVAD) application and the prognosis in dilated cardiomyopathy. Methods Patients was divided to two groups ac-cording to the prognosis (weaning or transplantation) after LVAD application. Left ventricular samples were collected from the patients (weaning group n= 10, transplanted group n=8) at the time the LVADs were implanted, and again during cardiac transplantation ( n = 8 ). The content of neutral salt soluble collagen (NSC) and acid soluble collagen (ASC) were measured by Sired collagen assay and total collagen and insoluble collagen (ISC) by quantification of hydroxyproline. Moreover, protein quantification of each collagen fraction was performed simultaneously. Results Before LVAD implantation all collagen fraction and their protein contents were higher in the weaning group than that in the transplanted group ( P <0.05), but the difference in the collagen fraction disappeared after LVAD support. Comparison of the pre- and post-LVAD subgroups of the transplanted group showed an increase of NSC and its protein content and total hydroxyproline after LVAD support (P<0.05). Conclusion The significances of myocardial intersititial remodeling in DCM are not identical. Some myocardial collagen and protein content increases may be related to good prognosis. The mechanism of LVAD improving cardiac function may be related to the changes of myocardial intersitial collagen.
ABSTRACT
Introdução: A utilização de dispositivos de assistência ventricular esquerda (DAVE) proporciona melhor manejo dos pacientes que necessitam de métodos alternativos como ponte para o transplante cardíaco. Parcela significativa dos pacientes sob uso de DAVE desenvolve falência de ventrículo direito (VD), com elevada mortalidade. Propusemos estudo experimental para desenvolvimento de método de descompressão do VD em pacientes sob assistência mecânica esquerda e disfunção biventricular. Método: Foi realizado estudo experimental em cães adultos, com disfunção biventricular em fibrilação ventricular, mantidos em uso de DAVE com bomba centrífuga. Os animais foram divididos em dois grupos. No Grupo A, foi realizada descompressão do VD através de anastomose cavo-pulmonar, com anastomose da veia cava superior na artéria pulmonar direita. No grupo B, não foi realizado o "shunt". Após o preparo inicial foi iniciada assistência circulatória átrio esquerdo-aorta. Foram realizadas medidas hemodinâmicas e laboratoriais no momento inicial e aos 30, 60 e 90 minutos de assistência nos dois grupos. Resultados: Os dados hemodinâmicos e laboratoriais iniciais foram semelhantes nos dois grupos. No Grupo A, houve melhora da pressão arterial media (p<0,0001) durante a assistência. O fluxo pulmonar também foi maior no grupo A (p<0,0001), resultando em maior fluxo na bomba centrífuga, principalmente aos 90 min(1,2L/min X 0,5L/min, p<0,0001). A dosagem de lactato sérico no último momento de estudo foi menor no grupo A (27,6mg/dL versus 47,6mg/dL, p<0,05). Conclusão: Concluímos que a anastomose cavo-pulmonar promove descompressão do VD em modelo de disfunção bi-ventricular aguda sob assistência circulatória isolada do ventrículo esquerdo. A descompressão do VD leva a aumento do fluxo pulmonar e melhor desempenho hemodinâmico da assistência ao ventrículo esquerdo.
Introduction: The use of Left Ventricular Assist Devices promotes better clinical handling of patients in the need of alternative methods as bridge to heart transplant. A significant part of them develop right ventricle failure, leading to high death incidence. We have proposed an experimental study for the development of a method to decompress the right ventricle in biventricular failure patients under Left Ventricular Assist Devices . Method: Experimental study with adult dogs with acute biventricular failure in ventricular fibrillation under left assist device by centrifugal pump. The animals were divided in 2 groups. In Group A decompression of RV was made by cavo-pulmonary anastomosis between superior vena cava and right pulmonary artery. In Group B the anastomosis was not performed. After initial preparation left atrium-aorta circulatory support begun. Hemodinamic and laboratory measures were taken at start time and at 30, 60 and 90 minutes of circulatory support. Results: Initial laboratory and haemodinamic data were similar in both groups. Group A had better mean arterial pressure during support(p<0,0001). Pulmonary blood flow was higher in Group A resulting in higher pump flow, mainly at 90 minutes(1,2L/minX0,5L/min, p<0,0001). Serum lactate was lower at 90 minutes in Group A(27,6mg/dL x 47,6mg/dL, p<0,05). Conclusion: We conclude that the cavo-pulmonary anastomosis led to right ventricle decompression in an experimental model of acute biventricular failure under isolated left ventricle circulatory support. The right ventricle decompression generated enhancement in pulmonary blood flow and better circulatory support performance.
Subject(s)
Animals , Dogs , Heart Bypass, Right , Heart Failure , Heart-Assist DevicesABSTRACT
BACKGROUND: The recent trend of an increasing number of patients with acute cardiogenic shock or chronic congestive heart failure following myocardial infarction, as well as the considerable number who can not be weaned from cardiopulmonary bypass after open heart surgery, call for immediate efforts to develop affordable ventricular assist devices that are suitable for the Korean physique. Recently, a pneumatic pulsatile ventricular assist device (VAD), named DKUH-75, has been developed by the Department of Biomedical Engineering, in collaboration with the Department of Thoracic and Cardiovascular Surgery of Dankook University College of Medicine. The feasibility of the DKUH-75 VAD was evaluated on the bases of common hemodynamic variables and echocardiographic measurements in pigs, which are subjected to an acute cardiogenic shock state following myocardial infarction, using a novel coronary artery ligation method employing the ischemic preconditioning concept. MATERIAL AND METHOD: Acute cardiogenic shock was induced in 10 Yorkshire Landrace Duroc strain pigs by ligating the left anterior descending coronary artery via an ischemic preconditioning process. The hemodynamic variables were monitored, with epicardial echocardiographic measurements performed before and one hour after the ligation. The DKUH-75 VAD was implanted into 5 pigs one hour after the onset of the shock. The hemodynamic variables and echocardiographic measurements were taken one hour after installation of the VAD. RESULT: The systolic, diastolic and mean systemic arterial pressures were significantly decreased in all the experimental animals one hour after the ligation. The systolic, diastolic and mean pulmonary arterial pressures were increased (Eds note: this completely contradicts the preceding statement? However, if you mean the non-experimental animals this should be stated?). The left ventricular end diastolic pressure (LVEDP) was increased, but the cardiac index decreased. An increase in the left ventricular end systolic dimension and decreases in the fractional shortening and ejection fraction were observed all animals one hour after the coronary artery ligation. In all 5 of the VAD implanted pigs, the systolic and mean systemic arterial pressures were increased, and the pulmonary arterial pressures decreased one hour after the implantation; the LVEDP decreased, but the cardiac index was significantly increased. In the echocardiographic measurements, the left ventricular end systolic dimension decreased after the implantation of the VAD, but the fractional shortening and ejection fraction significantly increased. CONCLUSION: Significant improvements in the hemodynamic variables and echocardiographic measurements were observed in the 5 VAD implanted animals one hour after installation, which had been subjected to an acute cardiogenic shock state by ligation of the coronary artery, indicating that the DKUH-75 VAD could help in the recovery of the myocardial function. This suggests that the DKUH-75 VAD is feasible in the short term in relation to an acute cardiogenic shock state due to myocardial infarction.
Subject(s)
Animals , Humans , Arterial Pressure , Biomedical Engineering , Blood Pressure , Cardiopulmonary Bypass , Cooperative Behavior , Coronary Vessels , Echocardiography , Heart Failure , Heart-Assist Devices , Hemodynamics , Ischemic Preconditioning , Ligation , Myocardial Infarction , Shock , Shock, Cardiogenic , Swine , Thoracic SurgeryABSTRACT
The patient was an eight-year-old female. She was diagnosed as dilated cardiomyopathy. She was supported with bi-ventricular assist because of heart failure for 15 days. After 7 days, she was suffered from prerenal type ARF and support with continuous veno-veno hemodyalisis (CVVHD). And then heart transplantation was performed, heart donor's blood type was A. Immune suppressants were used after due consideration for renal toxicity. ARF was resolved on post operative 14th day. She was discharged on post operative 52nd day without any specific post operative complication. She has been followed up without any immune rejection reaction upto 14 months.
Subject(s)
Female , Humans , Acute Kidney Injury , Cardiomyopathy, Dilated , Heart Failure , Heart Transplantation , Heart , Heart-Assist DevicesABSTRACT
Objective To observe the response of the guiding vane to axial flow pump by testing two types of miniature axial flow pump,which have been developed by our group in recent years.Methods Two types of axial flow pump were tested in a mock circulation apparatus.Results The outputs of the two types of miniature axial flow pump all attain 5L/min against the pressure of 13.332kPa,which is enough for left ventricular assistance.The outputs are similarly related to their pre-load and after-load pressure.In this study,the guiding vane does not produce a significant affection on the hydrodynamic characteristic of the axial follow pump.Conclusion The guiding vane may be neglected in the design to improve the blood compatibility of a axial flow pump heart assist device.
ABSTRACT
This paper mainly introduces the development of blood pump.Firstly,the latest research on blood pump is explained and the advantages and disadvantages of different kinds of blood pumps are compared.Then,the flow visualization,design and calculation of blood pump are introduced.At last,the questions during the blood pump development such as hemolysis and thrombus,are analyzed.It is suggested that a good blood pump should be miniature,implantable,portable and long-lasting.
ABSTRACT
Korean artificial heart(AnyHeart) is a single-pieced and implantable bi-ventricular pulsatile pump adapting a moving actuator mechanism. The authors report a case of clinical application of AnyHeart as a life-saving device for the patients with end-stage heart disease combined with biventricular failure.
Subject(s)
Humans , Heart Diseases , Heart Failure , Heart, ArtificialABSTRACT
BACKGROUND: The surgical technique for biventricular assist device(BVAD) implantation has mainly consisted of cannulation procedures. A median sternotomy has been the technique of choice as it gives a surgeon an excellent exposure of the heart. However, considering that most patients require a future sternotomy or already have a previous sternotomy, sternotomy-related complication remains a major concern in BVAD implantation. Based on this consideration as well as the clinical experiences of conventional heart surgery, the authors have hypothesized that the cardiac chambers for BVAD cannulation can be approached from the right side of the heart. The purpose of this study to develop a novel surgical technique of right thoracotomy for BVAD implantation in an animal study. MATERIAL AND METHOD: For last two years, 16 (11 calves, 3 canines, and 2 sheep) out of 30 experimental animals with AnyHeart implantation underwent a right thoracotomy. The device was used as an implantable BVAD in 14 animals, a wearable BVAD in 1, and an implantable LVAD in 1. The chest cavity was entered through the 4th intercostal space or the 5th periosteal bed. As for the BVAD use, a right inflow cannula was inserted into the right atrial free wall and a right outflow cannula was grafted onto the main pulmonary artery. A left inflow cannula was inserted into the interatrial groove and a left outflow cannula was grafted on the innominate artery of the ascending aorta. The connecting tubeswere brought out through the thoracotomy wound and connected to the pump located in the subcutaneous pocket at the right flank. RESULT: Except for the 5 animals for a fitting test or during the early learning curve, all recovered smoothly from the procedures. The inflow drainage allowed the pump output 6.5 L/min at the maximum with 3-3.5 L/min in an average. Of the survivors, there noted no procedure-related mortality or morbidity. Necropsy findings demonstrated the well-positioned cannula tips in the each cardiac chamber. CONCLUSION: The technique of right thoracotomy approach in AnyHeart implantation is simple, safe, and reproducible. As it can avoid sternotomy-orresternotomy-related complications, the authors suggest a right thoracotomy approach as one of the techniques for BVAD implantation. The technique would also be suggested as an alternatitve for a median sternotomy in a certain group of patients with various VAD implantations.
Subject(s)
Animals , Humans , Aorta , Brachiocephalic Trunk , Catheterization , Catheters , Drainage , Heart , Heart, Artificial , Learning Curve , Mortality , Pulmonary Artery , Sternotomy , Survivors , Thoracic Surgery , Thoracotomy , Thorax , Transplants , Wounds and InjuriesABSTRACT
A 17 year-old high school girl was admitted for anterior chest pain. Pulmonary edema and circulatory collapse progressed in spite of the medical treatment and intra-aortic balloon pump. Left ventricular assist device(LVAD, Bio-Pump, Medtronic Bio-Med, USA) was instituted under the impression of acute fulminant myocarditis. The inlet cannula was inserted in the left atrium(LA) via left submammary anterior thoracotomy. Biopsy was taken from left atrial appendage. The outlet cannula inserted to the left femoral artery using PTFE cuff. After 158 hours of extracorporeal circulation, LVAD was able to be weaned successfully with nearly normalized LV motion on echocardiogram. Coxsakievirus was identified with immunochemistry and serum neutralization test. She was discharged without any heart failure symptoms after 23 days of hopitalization.
Subject(s)
Adolescent , Female , Humans , Atrial Appendage , Bays , Biopsy , Catheters , Chest Pain , Extracorporeal Circulation , Femoral Artery , Heart Failure , Heart-Assist Devices , Immunochemistry , Myocarditis , Neutralization Tests , Polytetrafluoroethylene , Pulmonary Edema , Shock , ThoracotomyABSTRACT
BACKGROUND: The purpose of this study was to investigate the possibility of using the moving-actuator type total artificial heart as a biventricular assist device(BVAD) and to establish a safe and effective animal model for the implantation of a BVAD. MATERIAL AND METHOD: Seven Corridale sheep were used in this study wherein left thoracotomy was performed. The left and right outflow cannulas were anastomosed to the descending thoracic aorta and the main pulmonary artery, and the left and right inflow cannulas were inserted to the left atrium and the right atrial appendage. The devices were positioned in the preperitoneal pocket in 4 sheep, in the left pleural cavity in 2 sheep, and externally in 1 sheep. The aPTT was maintained between the 2 and 2.5 times the range that of the baseline. RESULT: Cannulation was carried out successfully in all cases. There was no case of operative death or immediate postoperative death. Three sheep expired postoperatively on the 2nd day because of thromboembolism, an artificial ventilator accident, and device and respiratory failure. Three other sheep died postoperatively on the 4th day because of acute renal and respiratory failure following thromboembolism. One sheep survived for 28 days. Experimentation on this animal terminated due to an electrical short-circuit caused by motor wire erosion. Thrombi were found on the valves of 4 out of 7 animals, especially on the connection between valves and the device. However , there was no thrombus in the cannulas. CONCLUSION: In conclusion, left thoracotomy for insertion of 4 cannulas and placement of device in the preperitoneal space is the safe and effective operative technique in ovine for testing in-vivo biocompatibility of the BVAD. Furthermore, it may be possible to use a moving-actuator type total artificial heart as a BVAD if technical improvements for reducing thromboembolism are carried out.
Subject(s)
Animals , Aorta, Thoracic , Atrial Appendage , Catheterization , Catheters , Heart Atria , Heart, Artificial , Models, Animal , Pleural Cavity , Pulmonary Artery , Respiratory Insufficiency , Sheep , Thoracotomy , Thromboembolism , Thrombosis , Ventilators, MechanicalABSTRACT
BACKGROUND: To review the experience that used both ventricular assist device(VAD) and extracorporeal membrane oxygenation(ECMO) for children with congential heart disease requiring postcardiotomy mechanical circulatory support. MATERIAL AND METHOD: Between March 1993 and May 1995, we applied mechanical assist device using centrifugal pump to the 16 patients who failed to be weaned from cardiopulmonary bypass(n=15) or had been in cardiogenic shock in intensive care unit(n=1). The diagnosis were all congenital heart diseases and the ages of patients ranged from 20 days to 10 years (mean age=2.5+/-3.5 years). RESULT: The methods of mechanical circulatory support were LVAD(n=13), BVAD (n=1), and ECMO(n=2). The mean assist times were 54.0+/-23.7 hours. Post-assist complications were in orders: bleeding, acute renal failure, ventricular failure, respiratory failure, infection, and neurologic complication. It was possible for 9 patients(56.3%) to be weaned from assist device and 5 patients(31.3%) were discharged from hospital. There was no statistical significant between hospital discharged group and undischarged group by age, body weight, cardiopulmonary bypass time, and assist time. CONCLUSIONS: The ventricular assist device is an effective modality in salvaging the patient who failed to be weaned from cardiopulmonary bypass, but multiple factors must be considered for improving the results of mechanical circulatory support ; such as patient selection, optimal time of starting the assist device, and prevention and management of the complications.